Q9AFC7 AF NFT

Devancosaminyl-vancomycin vancosaminetransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicd3sz57yuwh5lefbdrrcc7z2exubpshxbqn3o2rrtnix4vmzvu44/metadata.json
IPFS of structure file: 
bafybeig7ra7zcrj7zmxk4wwb6elzr7pvqecuabkc344d3i2v7fmqo57w4y/AF-Q9AFC7-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xB44F19a0cb161828322eEEd13F55d4C3C34938d2
First NFT owner address (bech32): 
genesis1k383ngxtzcvzsv3wamgn74w5c0p5jwxjy9e46q
Current NFT ID #160971 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
160971
Accession (UniProt):
Q9AFC7
Name::
Devancosaminyl-vancomycin vancosaminetransferase
Experimental Method:
Predicted structure
Sequence source:
AMYCOLATOPSIS ORIENTALIS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q9AFC7 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q9AFC7|GTFD_AMYOR Devancosaminyl-vancomycin vancosaminetransferase OS=Amycolatopsis orientalis OX=31958 GN=gtfD PE=1 SV=1 MRVLLSVCGTRGDVEIGVALADRLKALGVQTRMCAPPAAEERLAEVGVPHVPVGLPQHMMLQEGMPPPPPEEEQRLAAMTVEMQFDAVPGAAEGCAAVVAVGDLAAATGVRSVAEKLGLPFFYSVPSPVYLASPHLPPAYDEPTTPGVTDIRVLWEERAARFADRYGPTLNRRRAEIGLPPVEDVFGYGHGERPCWPADPVLAPLQPDVDAVQTGAWLLSDERPLPPELEAFLAAGSPPVHIGFGSSSGRGIADAAKVAVEAIRAQGRRVILSRGWTELVLPDDRDDCFAIDEVNFQALFRRVAAVIHHGSAGTEHVATRAGVPQLVIPRNTDQPYFAGRVAALGIGVAHDGPTPTFESLSAALTTVLAPETRARAEAVAGMVLTDGAAAAADLVLAAVGREKPAVPA